MedTrace Logo

Biomarkers of Cognitive Impairment in Blood Cells

NCT05582941 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 48

Last updated 2025-07-04

No results posted yet for this study

Summary

The aim of this study is to identify transcriptomic biomarkers in blood cells to diagnose early cognitive impairment. This would allow preventing the development of severe pathologies, such as Alzheimer Disease. In addition, this project will analyse the influence of adiposity, obesity, nutritional habits and physical activity on cognition.

Conditions

  • Mild Cognitive Impairment Due to Alzheimer's Disease
  • Dementia Due to Alzheimer's Disease (Disorder)

Interventions

OTHER

No intervention will be performed.

No intervention will be performed.

Sponsors & Collaborators

  • Fundació d'investigació Sanitària de les Illes Balears

    collaborator OTHER_GOV

  • Consorcio Centro de Investigación Biomédica en Red (CIBER)

    collaborator OTHER_GOV

  • University of the Balearic Islands

    lead OTHER

Principal Investigators

  • Paula Oliver, Professor · University of the Balearic Islands

Eligibility

Min Age
55 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-04-01
Primary Completion
2023-05-31
Completion
2023-05-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05582941 on ClinicalTrials.gov